Recommendations for Patients with COVID-19 On the
Post# of 145904
![](/assets/46931549/no_avatar_available_thumb.jpg)
On the basis of the preliminary report from the RECOVERY trial, the COVID-19 Treatment Guidelines Panel (the Panel) recommends using dexamethasone 6 mg per day for up to 10 days or until hospital discharge, whichever comes first, for the treatment of COVID-19 in hospitalized patients who are mechanically ventilated (AI) and in hospitalized patients who require supplemental oxygen but who are not mechanically ventilated (BI).
The Panel recommends against using dexamethasone for the treatment of COVID-19 in patients who do not require supplemental oxygen (AI).
If dexamethasone is not available, the Panel recommends using alternative glucocorticoids such as prednisone, methylprednisolone, or hydrocortisone (see Additional Considerations below for dosing recommendations) (AIII).
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)